TRVI Trevi Therapeutics | $14.40 -0.1% | 9/25/2026 | | Reiterated Rating | | Outperform | 00.00% | View details for Oppenheimer rating of Trevi Therapeutics (NASDAQ:TRVI) on 9/25/2026 |
OKTA Okta | $202.18 +3.6% | 9/24/2026 | | Boost Price Target | $190.00 ➝ $227.00 | Outperform | 00.00% | View details for Oppenheimer rating of Okta (NASDAQ:OKTA) on 9/24/2026 |
KNF Knife River | $53.41 -2.1% | 9/24/2026 | | Lower Price Target | $90.00 ➝ $80.00 | Outperform | 00.00% | View details for Oppenheimer rating of Knife River (NYSE:KNF) on 9/24/2026 |
CTVA Corteva | $77.71 -1.0% | 9/24/2026 | | Reiterated Rating | $95.00 | Outperform | 00.00% | View details for Oppenheimer rating of Corteva (NYSE:CTVA) on 9/24/2026 |
HRMY Harmony Biosciences | $40.01 -3.0% | 9/24/2026 | | Reiterated Rating | | Outperform | 00.00% | View details for Oppenheimer rating of Harmony Biosciences (NASDAQ:HRMY) on 9/24/2026 |
IONS Ionis Pharmaceuticals | $45.57 +2.4% | 9/24/2026 | | Reiterated Rating | $85.00 | Outperform | 00.00% | View details for Oppenheimer rating of Ionis Pharmaceuticals (NASDAQ:IONS) on 9/24/2026 |
DT Dynatrace | $57.85 -0.2% | 9/24/2026 | | Boost Price Target | $60.00 ➝ $71.00 | Outperform | 00.00% | View details for Oppenheimer rating of Dynatrace (NYSE:DT) on 9/24/2026 |
MCD McDonald's | $233.32 -1.3% | 9/24/2026 | | Lower Price Target | $325.00 ➝ $295.00 | Outperform | 00.00% | View details for Oppenheimer rating of McDonald’s (NYSE:MCD) on 9/24/2026 |
NKE NIKE | $36.40 +1.8% | 9/23/2026 | | Set Price Target | $60.00 ➝ $52.00 | Outperform | 00.00% | View details for Oppenheimer rating of NIKE (NYSE:NKE) on 9/23/2026 |
AMRX Amneal Pharmaceuticals | $20.50 +3.7% | 9/23/2026 | | Initiated Coverage | $27.00 | Outperform | 00.00% | View details for Oppenheimer rating of Amneal Pharmaceuticals (NASDAQ:AMRX) on 9/23/2026 |
Get the Latest News and Ratings for Your Stocks Enter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter.
|
VTRS Viatris | $18.27 +2.5% | 9/23/2026 | | Initiated Coverage | $25.00 | Outperform | 00.00% | View details for Oppenheimer rating of Viatris (NASDAQ:VTRS) on 9/23/2026 |
ANIP ANI Pharmaceuticals | $74.83 +1.1% | 9/23/2026 | | Initiated Coverage | $85.00 | Market Perform | 00.00% | View details for Oppenheimer rating of ANI Pharmaceuticals (NASDAQ:ANIP) on 9/23/2026 |
VNDA Vanda Pharmaceuticals | $5.17 +2.4% | 9/23/2026 | | Initiated Coverage | $10.00 | Outperform | 00.00% | View details for Oppenheimer rating of Vanda Pharmaceuticals (NASDAQ:VNDA) on 9/23/2026 |
AZO AutoZone | $2,917.83 +1.6% | 9/23/2026 | | Set Price Target | $3,400.00 | | 00.00% | View details for Oppenheimer rating of AutoZone (NYSE:AZO) on 9/23/2026 |
ACAD ACADIA Pharmaceuticals | $20.53 -0.7% | 9/23/2026 | | Reiterated Rating | | Market Perform | 00.00% | View details for Oppenheimer rating of ACADIA Pharmaceuticals (NASDAQ:ACAD) on 9/23/2026 |
AMGN Amgen | $418.13 +0.8% | 9/23/2026 | | Reiterated Rating | | Outperform | 00.00% | View details for Oppenheimer rating of Amgen (NASDAQ:AMGN) on 9/23/2026 |
COLL Collegium Pharmaceutical | $22.63 +0.4% | 9/23/2026 | | Initiated Coverage | $50.00 | Outperform | 00.00% | View details for Oppenheimer rating of Collegium Pharmaceutical (NASDAQ:COLL) on 9/23/2026 |
CRMD CorMedix | $7.89 +0.5% | 9/23/2026 | | Initiated Coverage | $15.00 | Outperform | 00.00% | View details for Oppenheimer rating of CorMedix (NASDAQ:CRMD) on 9/23/2026 |
INVA Innoviva | $21.23 +2.4% | 9/23/2026 | | Initiated Coverage | $35.00 | Outperform | 00.00% | View details for Oppenheimer rating of Innoviva (NASDAQ:INVA) on 9/23/2026 |
PCRX Pacira BioSciences | $25.39 +1.1% | 9/23/2026 | | Initiated Coverage | $32.00 | Outperform | 00.00% | View details for Oppenheimer rating of Pacira BioSciences (NASDAQ:PCRX) on 9/23/2026 |
TEVA Teva Pharmaceutical Industries | $38.84 -0.9% | 9/23/2026 | | Initiated Coverage | $50.00 | Outperform | 00.00% | View details for Oppenheimer rating of Teva Pharmaceutical Industries (NYSE:TEVA) on 9/23/2026 |
TTC Toro | $97.05 -0.1% | 9/23/2026 | | Initiated Coverage | $120.00 | Outperform | 00.00% | View details for Oppenheimer rating of Toro (NYSE:TTC) on 9/23/2026 |
VKTX Viking Therapeutics | $33.03 -7.1% | 9/22/2026 | | Set Price Target | $120.00 | | 00.00% | View details for Oppenheimer rating of Viking Therapeutics (NASDAQ:VKTX) on 9/22/2026 |
TYRA Tyra Biosciences | $21.45 -1.4% | 9/22/2026 | | Reiterated Rating | $50.00 ➝ $40.00 | Outperform | 00.00% | View details for Oppenheimer rating of Tyra Biosciences (NASDAQ:TYRA) on 9/22/2026 |
CNTB Connect Biopharma | $1.08
| 9/22/2026 | | Lower Price Target | $5.00 | Outperform | 00.00% | View details for Oppenheimer rating of Connect Biopharma (NASDAQ:CNTB) on 9/22/2026 |
KBR KBR | $34.78 +0.7% | 9/22/2026 | | Lower Price Target | $60.00 ➝ $50.00 | Outperform | 00.00% | View details for Oppenheimer rating of KBR (NYSE:KBR) on 9/22/2026 |
MSFT Microsoft | $509.22 -1.3% | 9/22/2026 | | Boost Price Target | $515.00 ➝ $570.00 | Outperform | 00.00% | View details for Oppenheimer rating of Microsoft (NASDAQ:MSFT) on 9/22/2026 |
COHR Coherent | $282.57 -4.5% | 9/22/2026 | | Upgrade | | Outperform ➝ Buy | 00.00% | View details for Oppenheimer rating of Coherent (NYSE:COHR) on 9/22/2026 |
TPB Turning Point Brands | $60.65 -2.3% | 9/22/2026 | | Lower Price Target | $130.00 ➝ $90.00 | Outperform | 00.00% | View details for Oppenheimer rating of Turning Point Brands (NYSE:TPB) on 9/22/2026 |
TSLA Tesla | $357.45 -3.9% | 9/21/2026 | | Reiterated Rating | | Market Perform | 00.00% | View details for Oppenheimer rating of Tesla (NASDAQ:TSLA) on 9/21/2026 |
BSX Boston Scientific | $44.11 +0.4% | 9/21/2026 | | Lower Price Target | $85.00 ➝ $65.00 | Outperform | 00.00% | View details for Oppenheimer rating of Boston Scientific (NYSE:BSX) on 9/21/2026 |
AMRZ Amrize | $38.11 -0.3% | 9/18/2026 | | Lower Price Target | $62.00 ➝ $55.00 | Outperform | 00.00% | View details for Oppenheimer rating of Amrize (NYSE:AMRZ) on 9/18/2026 |
AZO AutoZone | $2,917.83 +1.6% | 9/18/2026 | | Lower Price Target | $4,300.00 ➝ $3,500.00 | Outperform | 00.00% | View details for Oppenheimer rating of AutoZone (NYSE:AZO) on 9/18/2026 |
CAPR Capricor Therapeutics | $8.71 +4.2% | 9/17/2026 | | Reiterated Rating | | Outperform | 00.00% | View details for Oppenheimer rating of Capricor Therapeutics (NASDAQ:CAPR) on 9/17/2026 |
JEF Jefferies Financial Group | $47.15 -1.1% | 9/17/2026 | | Reiterated Rating | $76.00 | Outperform | 00.00% | View details for Oppenheimer rating of Jefferies Financial Group (NYSE:JEF) on 9/17/2026 |
KOPN Kopin | $4.75 -4.8% | 9/17/2026 | | Initiated Coverage | $7.00 | Outperform | 00.00% | View details for Oppenheimer rating of Kopin (NASDAQ:KOPN) on 9/17/2026 |
CRM Salesforce | $227.17 -2.9% | 9/17/2026 | | Reiterated Rating | | Outperform | 00.00% | View details for Oppenheimer rating of Salesforce (NYSE:CRM) on 9/17/2026 |
COST Costco Wholesale | $922.92 +0.0% | 9/16/2026 | | Reiterated Rating | $1,160.00 | Outperform | 00.00% | View details for Oppenheimer rating of Costco Wholesale (NASDAQ:COST) on 9/16/2026 |
FPS Forgent Power Solutions | $36.53 -6.3% | 9/16/2026 | | Reiterated Rating | $60.00 | Outperform | 00.00% | View details for Oppenheimer rating of Forgent Power Solutions (NYSE:FPS) on 9/16/2026 |
JHX James Hardie Industries | $25.42 -2.6% | 9/16/2026 | | Reiterated Rating | $36.00 | Outperform | 00.00% | View details for Oppenheimer rating of James Hardie Industries (NYSE:JHX) on 9/16/2026 |
Major Buy Alert Issued for September 30th (Ad) Keith Kaplan has invested $17 million into his own AI research tools, building a platform now used by 180,000 people worldwide.
His system has flagged a handful of stocks worth watching ahead of September 30th.
See which stocks his AI research platform is flagging right now. See which stocks his AI research platform is flagging now |
ASTH Astrana Health | $35.13 -3.4% | 9/15/2026 | | Initiated Coverage | $53.00 | Outperform | 00.00% | View details for Oppenheimer rating of Astrana Health (NASDAQ:ASTH) on 9/15/2026 |
VSH Vishay Intertechnology | $32.25 -0.9% | 9/15/2026 | | Initiated Coverage | $42.00 | Outperform | 00.00% | View details for Oppenheimer rating of Vishay Intertechnology (NYSE:VSH) on 9/15/2026 |
ETSY Etsy | $68.94 +0.7% | 9/15/2026 | | Upgrade | $90.00 | Market Perform ➝ Outperform | 00.00% | View details for Oppenheimer rating of Etsy (NYSE:ETSY) on 9/15/2026 |
DRI Darden Restaurants | $197.11 -1.3% | 9/15/2026 | | Boost Price Target | $235.00 ➝ $245.00 | Outperform | 00.00% | View details for Oppenheimer rating of Darden Restaurants (NYSE:DRI) on 9/15/2026 |
DFTX Definium Therapeutics | $38.41 +6.2% | 9/14/2026 | | Reiterated Rating | $75.00 | Outperform | 00.00% | View details for Oppenheimer rating of Definium Therapeutics (NASDAQ:DFTX) on 9/14/2026 |
RBLX Roblox | $41.88 -9.8% | 9/11/2026 | | Reiterated Rating | | Outperform | 00.00% | View details for Oppenheimer rating of Roblox (NYSE:RBLX) on 9/11/2026 |
AEHR Aehr Test Systems | $98.49 -5.7% | 9/10/2026 | | Initiated Coverage | $120.00 | Outperform | 00.00% | View details for Oppenheimer rating of Aehr Test Systems (NASDAQ:AEHR) on 9/10/2026 |
AAPL Apple | $338.40 -0.8% | 9/10/2026 | | Reiterated Rating | | Market Perform | 00.00% | View details for Oppenheimer rating of Apple (NASDAQ:AAPL) on 9/10/2026 |
SKIL Skillsoft | $5.97 +0.4% | 9/10/2026 | | Reiterated Rating | | Market Perform | 00.00% | View details for Oppenheimer rating of Skillsoft (NYSE:SKIL) on 9/10/2026 |
ZWS Zurn Elkay Water Solutions Cor | $46.77 +0.3% | 9/9/2026 | | Boost Price Target | $58.00 ➝ $60.00 | Outperform | 00.00% | View details for Oppenheimer rating of Zurn Elkay Water Solutions Cor (NYSE:ZWS) on 9/9/2026 |
RAL Ralliant | $69.88 -0.2% | 9/9/2026 | | Boost Price Target | $75.00 ➝ $80.00 | Outperform | 00.00% | View details for Oppenheimer rating of Ralliant (NYSE:RAL) on 9/9/2026 |
IEX IDEX | $231.34 +0.5% | 9/9/2026 | | Boost Price Target | $265.00 ➝ $270.00 | Outperform | 00.00% | View details for Oppenheimer rating of IDEX (NYSE:IEX) on 9/9/2026 |
ORA Ormat Technologies | $90.29 -3.6% | 9/9/2026 | | Boost Price Target | $141.00 ➝ $145.00 | Outperform | 00.00% | View details for Oppenheimer rating of Ormat Technologies (NYSE:ORA) on 9/9/2026 |
PRCT PROCEPT BioRobotics | $17.25 +0.3% | 9/9/2026 | | Reiterated Rating | | Market Perform | 00.00% | View details for Oppenheimer rating of PROCEPT BioRobotics (NASDAQ:PRCT) on 9/9/2026 |
AKTS Aktis Oncology | $19.35 -0.4% | 9/9/2026 | | Initiated Coverage | $40.00 | Outperform | 00.00% | View details for Oppenheimer rating of Aktis Oncology (NASDAQ:AKTS) on 9/9/2026 |
AKTS Aktis Oncology | $19.35 -0.4% | 9/9/2026 | | Initiated Coverage | $40.00 | Outperform | 00.00% | View details for Oppenheimer rating of Aktis Oncology (NASDAQ:AKTS) on 9/9/2026 |
DNA Ginkgo Bioworks | $10.52 -1.3% | 9/9/2026 | | Set Price Target | $5.00 | | 00.00% | View details for Oppenheimer rating of Ginkgo Bioworks (NYSE:DNA) on 9/9/2026 |
IRD Opus Genetics | $5.05 +6.1% | 9/9/2026 | | Boost Price Target | $10.00 ➝ $20.00 | Outperform | 00.00% | View details for Oppenheimer rating of Opus Genetics (NASDAQ:IRD) on 9/9/2026 |
PHVS Pharvaris | $31.91 -0.3% | 9/8/2026 | | Reiterated Rating | $75.00 | Outperform | 00.00% | View details for Oppenheimer rating of Pharvaris (NASDAQ:PHVS) on 9/8/2026 |
ENPH Enphase Energy | $30.91 -4.6% | 9/8/2026 | | Reiterated Rating | | Outperform | 00.00% | View details for Oppenheimer rating of Enphase Energy (NASDAQ:ENPH) on 9/8/2026 |
CLYM Climb Bio | $11.74 +0.7% | 9/8/2026 | | Boost Price Target | $18.00 ➝ $25.00 | Outperform | 00.00% | View details for Oppenheimer rating of Climb Bio (NASDAQ:CLYM) on 9/8/2026 |
TH Target Hospitality | $19.30 -6.2% | 9/8/2026 | | Boost Price Target | $24.00 ➝ $27.00 | Outperform | 00.00% | View details for Oppenheimer rating of Target Hospitality (NASDAQ:TH) on 9/8/2026 |
TTWO Take-Two Interactive Software | $202.35 +0.5% | 9/8/2026 | | Reiterated Rating | | Outperform | 00.00% | View details for Oppenheimer rating of Take-Two Interactive Software (NASDAQ:TTWO) on 9/8/2026 |
ADBE Adobe | $231.01 -1.9% | 9/8/2026 | | Reiterated Rating | | Market Perform | 00.00% | View details for Oppenheimer rating of Adobe (NASDAQ:ADBE) on 9/8/2026 |
ORCL Oracle | $132.64 -3.3% | 9/8/2026 | | Reiterated Rating | $235.00 ➝ $275.00 | Outperform | 00.00% | View details for Oppenheimer rating of Oracle (NYSE:ORCL) on 9/8/2026 |
PATH UiPath | $12.23 -1.9% | 9/4/2026 | | Reiterated Rating | | Market Perform | 00.00% | View details for Oppenheimer rating of UiPath (NYSE:PATH) on 9/4/2026 |
AMBA Ambarella | $68.68 -5.5% | 9/4/2026 | | Reiterated Rating | | Market Perform | 00.00% | View details for Oppenheimer rating of Ambarella (NASDAQ:AMBA) on 9/4/2026 |
GWRE Guidewire Software | $144.81 -0.5% | 9/4/2026 | | Boost Price Target | $200.00 ➝ $210.00 | Outperform | 00.00% | View details for Oppenheimer rating of Guidewire Software (NYSE:GWRE) on 9/4/2026 |
SNOW Snowflake | $328.33 -2.3% | 9/3/2026 | | Boost Price Target | $400.00 ➝ $475.00 | Outperform | 00.00% | View details for Oppenheimer rating of Snowflake (NYSE:SNOW) on 9/3/2026 |
CHPT ChargePoint | $8.73 -2.3% | 9/3/2026 | | Reiterated Rating | | Market Perform | 00.00% | View details for Oppenheimer rating of ChargePoint (NYSE:CHPT) on 9/3/2026 |
PANW Palo Alto Networks | $392.09 +4.6% | 9/2/2026 | | Reiterated Rating | $400.00 ➝ $450.00 | Outperform | 00.00% | View details for Oppenheimer rating of Palo Alto Networks (NASDAQ:PANW) on 9/2/2026 |
ALMS Alumis | $7.16 +0.8% | 9/2/2026 | | Lower Price Target | $55.00 ➝ $37.00 | Outperform | 00.00% | View details for Oppenheimer rating of Alumis (NASDAQ:ALMS) on 9/2/2026 |
SPCX SpaceX | $145.47 -2.2% | 9/2/2026 | | Boost Price Target | $250.00 ➝ $280.00 | Outperform | 00.00% | View details for Oppenheimer rating of SpaceX (NASDAQ:SPCX) on 9/2/2026 |
ASND Ascendis Pharma A/S | $230.05 +2.0% | 9/1/2026 | | Boost Price Target | $304.00 ➝ $312.00 | Outperform | 00.00% | View details for Oppenheimer rating of Ascendis Pharma A/S (NASDAQ:ASND) on 9/1/2026 |
RNG RingCentral | $76.04 -0.2% | 9/1/2026 | | Boost Price Target | $50.00 ➝ $85.00 | Outperform | 00.00% | View details for Oppenheimer rating of RingCentral (NYSE:RNG) on 9/1/2026 |
TKR Timken | $116.83 -0.5% | 9/1/2026 | | Set Price Target | $135.00 | | 00.00% | View details for Oppenheimer rating of Timken (NYSE:TKR) on 9/1/2026 |
TECX Tectonic Therapeutic | $23.51 -0.7% | 9/1/2026 | | Reiterated Rating | | Outperform | 00.00% | View details for Oppenheimer rating of Tectonic Therapeutic (NASDAQ:TECX) on 9/1/2026 |
AFRM Affirm | $67.21 -6.0% | 8/28/2026 | | Boost Price Target | $100.00 ➝ $104.00 | Outperform | 00.00% | View details for Oppenheimer rating of Affirm (NASDAQ:AFRM) on 8/28/2026 |
ESTC Elastic | $88.21 +0.1% | 8/28/2026 | | Boost Price Target | $100.00 ➝ $118.00 | Outperform | 00.00% | View details for Oppenheimer rating of Elastic (NYSE:ESTC) on 8/28/2026 |
MRVL Marvell Technology | $251.90 -3.8% | 8/28/2026 | | Boost Price Target | $300.00 ➝ $325.00 | Outperform | 00.00% | View details for Oppenheimer rating of Marvell Technology (NASDAQ:MRVL) on 8/28/2026 |
RVMD Revolution Medicines | $201.74 -1.6% | 8/27/2026 | | Boost Price Target | $230.00 ➝ $260.00 | Outperform | 00.00% | View details for Oppenheimer rating of Revolution Medicines (NASDAQ:RVMD) on 8/27/2026 |
NAVN Navan | $19.98 +2.9% | 8/27/2026 | | Boost Price Target | $30.00 ➝ $35.00 | Outperform | 00.00% | View details for Oppenheimer rating of Navan (NASDAQ:NAVN) on 8/27/2026 |
NVDA NVIDIA | $228.86 +1.7% | 8/27/2026 | | Set Price Target | $265.00 ➝ $315.00 | Outperform | 00.00% | View details for Oppenheimer rating of NVIDIA (NASDAQ:NVDA) on 8/27/2026 |
CRM Salesforce | $227.17 -2.9% | 8/27/2026 | | Reiterated Rating | $250.00 ➝ $275.00 | Outperform | 00.00% | View details for Oppenheimer rating of Salesforce (NYSE:CRM) on 8/27/2026 |
ARES Ares Management | $118.43 -2.9% | 8/27/2026 | | Boost Price Target | $151.00 ➝ $162.00 | Outperform | 00.00% | View details for Oppenheimer rating of Ares Management (NYSE:ARES) on 8/27/2026 |
BRZE Braze | $23.17 -4.9% | 8/27/2026 | | Boost Price Target | $30.00 ➝ $36.00 | Outperform | 00.00% | View details for Oppenheimer rating of Braze (NASDAQ:BRZE) on 8/27/2026 |
BX Blackstone | $114.52 -3.3% | 8/27/2026 | | Boost Price Target | $140.00 ➝ $171.00 | Outperform | 00.00% | View details for Oppenheimer rating of Blackstone (NYSE:BX) on 8/27/2026 |
HLNE Hamilton Lane | $84.96 -1.4% | 8/27/2026 | | Lower Price Target | $182.00 ➝ $181.00 | Outperform | 00.00% | View details for Oppenheimer rating of Hamilton Lane (NASDAQ:HLNE) on 8/27/2026 |
KKR KKR & Co. Inc. | $93.16 -3.6% | 8/27/2026 | | Boost Price Target | $139.00 ➝ $166.00 | Outperform | 00.00% | View details for Oppenheimer rating of KKR & Co. Inc. (NYSE:KKR) on 8/27/2026 |
NTNX Nutanix | $68.70 +1.0% | 8/27/2026 | | Boost Price Target | $80.00 ➝ $85.00 | Outperform | 00.00% | View details for Oppenheimer rating of Nutanix (NASDAQ:NTNX) on 8/27/2026 |
Major Buy Alert Issued for September 30th (Ad) Keith Kaplan has invested $17 million into his own AI research tools, building a platform now used by 180,000 people worldwide.
His system has flagged a handful of stocks worth watching ahead of September 30th.
See which stocks his AI research platform is flagging right now. See which stocks his AI research platform is flagging now |
OKTA Okta | $202.18 +3.6% | 8/27/2026 | | Boost Price Target | $170.00 ➝ $190.00 | Outperform | 00.00% | View details for Oppenheimer rating of Okta (NASDAQ:OKTA) on 8/27/2026 |
OWL Blue Owl Capital | $9.15 -1.9% | 8/27/2026 | | Boost Price Target | $15.00 ➝ $17.00 | Outperform | 00.00% | View details for Oppenheimer rating of Blue Owl Capital (NYSE:OWL) on 8/27/2026 |
RPC Ridgepost Capital | $7.35 -2.6% | 8/27/2026 | | Lower Price Target | $16.00 ➝ $15.00 | Outperform | 00.00% | View details for Oppenheimer rating of Ridgepost Capital (NYSE:RPC) on 8/27/2026 |
STEP StepStone Group | $43.11 -2.8% | 8/27/2026 | | Lower Price Target | $90.00 ➝ $88.00 | Outperform | 00.00% | View details for Oppenheimer rating of StepStone Group (NASDAQ:STEP) on 8/27/2026 |
DKS DICK'S Sporting Goods | $134.45 -1.5% | 8/26/2026 | | Lower Price Target | $270.00 ➝ $150.00 | Outperform | 00.00% | View details for Oppenheimer rating of DICK’S Sporting Goods (NYSE:DKS) on 8/26/2026 |
WT WisdomTree | $24.12 -0.9% | 8/26/2026 | | Boost Price Target | $22.00 ➝ $27.00 | Outperform | 00.00% | View details for Oppenheimer rating of WisdomTree (NYSE:WT) on 8/26/2026 |
INTU Intuit | $269.40 -2.3% | 8/26/2026 | | Lower Price Target | $406.00 ➝ $380.00 | Outperform | 00.00% | View details for Oppenheimer rating of Intuit (NASDAQ:INTU) on 8/26/2026 |
WMT Walmart | $108.73 +0.7% | 8/25/2026 | | Reiterated Rating | | Market Perform | 00.00% | View details for Oppenheimer rating of Walmart (NASDAQ:WMT) on 8/25/2026 |
DG Dollar General | $124.50 -0.3% | 8/25/2026 | | Reiterated Rating | $150.00 | Outperform | 00.00% | View details for Oppenheimer rating of Dollar General (NYSE:DG) on 8/25/2026 |
CAPR Capricor Therapeutics | $8.71 +4.2% | 8/25/2026 | | Upgrade | | Market Perform ➝ Outperform | 00.00% | View details for Oppenheimer rating of Capricor Therapeutics (NASDAQ:CAPR) on 8/25/2026 |